Abiopharma

New Form SCHEDULE 13G/A - ClearPoint Neuro, Inc. Filed: 2025-08-04 AccNo: 0000921895-25-002077 Size: 20 KB

New Form 6-K - Cellectis S.A. Filed: 2025-08-04 AccNo: 0000950170-25-102055 Size: 3 MB

New Form SCHEDULE 13G/A - ImageneBio, Inc. Filed: 2025-08-04 AccNo: 0001172661-25-002867 Size: 11 KB

New Form 4 - Phreesia, Inc. Filed: 2025-08-04 AccNo: 0001127602-25-019958 Size: 5 KB

HealthStream Announces Second Quarter 2025 Results

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Pablo Perversi to Join METTLER TOLEDO Board of Directors

New Form 4 - Simulations Plus, Inc. Filed: 2025-08-04 AccNo: 0001628280-25-037453 Size: 6 KB

New Form 4 - Phreesia, Inc. Filed: 2025-08-04 AccNo: 0001127602-25-019956 Size: 5 KB

New Form 4 - Inotiv, Inc. Filed: 2025-08-04 AccNo: 0001062993-25-013507 Size: 5 KB

New Form 4 - Cencora, Inc. Filed: 2025-08-04 AccNo: 0001765744-25-000004 Size: 4 KB

New Form 4 - Simulations Plus, Inc. Filed: 2025-08-04 AccNo: 0001628280-25-037449 Size: 4 KB

New Form 4 - Brookdale Senior Living Inc. Filed: 2025-08-04 AccNo: 0001332349-25-000124 Size: 4 KB

New Form 8-K - Encompass Health Corp Filed: 2025-08-04 AccNo: 0000785161-25-000049 Size: 8 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits